Attention - deficit hyperactivity disorder (ADHD) affects 3 % — 5 % of children and young people under 18 years old.1 The core
symptoms include inattention, impulsivity and hyperactivity leading to significant impairments in academic and social function and increased risk of substance misuse, unemployment, criminality and mental health problems.2 3 Early treatment is crucial to improve
symptoms and
reduce the
burden on the family and wider social and healthcare systems.4 With the increasing rates of diagnosis of ADHD, spending on ADHD medication has increased sevenfold between 1998 and 2005,5 and expenditure on medication treatment costs in the UK is now estimated at # 78 million per year.5 6 This has placed increasing financial
burden on health services and highlighted the need for more efficient and cost - effective services to diagnose and treat the condition.
Other findings for the person with the condition include improved adherence with medication,
reduced symptoms and improved social functioning and vocational activity.1 In addition, these interventions have been shown to
reduce distress and
burden in primary carers and improve family functioning.7